1. Home
  2. RGEN vs ALSN Comparison

RGEN vs ALSN Comparison

Compare RGEN & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ALSN
  • Stock Information
  • Founded
  • RGEN 1981
  • ALSN 1915
  • Country
  • RGEN United States
  • ALSN United States
  • Employees
  • RGEN N/A
  • ALSN N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ALSN Auto Parts:O.E.M.
  • Sector
  • RGEN Health Care
  • ALSN Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • ALSN Nasdaq
  • Market Cap
  • RGEN 6.5B
  • ALSN 7.2B
  • IPO Year
  • RGEN N/A
  • ALSN 2012
  • Fundamental
  • Price
  • RGEN $148.48
  • ALSN $81.59
  • Analyst Decision
  • RGEN Buy
  • ALSN Hold
  • Analyst Count
  • RGEN 11
  • ALSN 8
  • Target Price
  • RGEN $170.90
  • ALSN $97.38
  • AVG Volume (30 Days)
  • RGEN 1.1M
  • ALSN 773.8K
  • Earning Date
  • RGEN 10-28-2025
  • ALSN 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • ALSN 1.32%
  • EPS Growth
  • RGEN N/A
  • ALSN N/A
  • EPS
  • RGEN 0.03
  • ALSN 8.15
  • Revenue
  • RGEN $707,890,000.00
  • ALSN $3,069,000,000.00
  • Revenue This Year
  • RGEN $16.79
  • ALSN N/A
  • Revenue Next Year
  • RGEN $13.58
  • ALSN $0.70
  • P/E Ratio
  • RGEN $5,835.10
  • ALSN $10.01
  • Revenue Growth
  • RGEN 11.74
  • ALSN N/A
  • 52 Week Low
  • RGEN $102.97
  • ALSN $79.35
  • 52 Week High
  • RGEN $182.52
  • ALSN $122.53
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 51.00
  • ALSN 41.47
  • Support Level
  • RGEN $155.74
  • ALSN $79.95
  • Resistance Level
  • RGEN $169.87
  • ALSN $84.25
  • Average True Range (ATR)
  • RGEN 6.47
  • ALSN 1.94
  • MACD
  • RGEN -1.11
  • ALSN 0.21
  • Stochastic Oscillator
  • RGEN 18.98
  • ALSN 44.01

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in class 4 through 8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: